CLICK-MS: CLadribine tablets: Observational evaluation of effectIveness and patient-reported outcomes (PROs) in suboptimally Controlled patients previously taKing injectable disease-modifying drugs (DMDs) for relapsing forms of Multiple Sclerosis (RMS)

April 07, 2021
https://clinicaltrials.gov/ct2/show/NCT03933215
Multiple Sclerosis
Principal Investigator: Mirela Cerghet, MD
Multiple Sclerosis, Pathologic Processes, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System, Demyelinating Diseases
Accepting Participants
313-916-4578